Plasma Amyloid-β Oligomerization Assay as a Pre-Screening Test for Amyloid Status

The Alzheimer Center Amsterdam is supported by Stichting Alzheimer Nederland and Stichting VUmc fonds. Research of the Alzheimer center Amsterdam is part of the neurodegeneration research program of Amsterdam Neuroscience. The clinical database structure was developed with funding from Stichting Dioraphte. The VUmc Biobank is supported by VUmc. The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under EMIF grant agreement no. 115372, resources of which are composed of financial contribution from the European Unions Seventh Framework Programme (FP7/2007-2013) and EFPIA companies in kind contribution.